Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan Receives Approval for Generic Version of NuLytely
PR-Canada
Sunday, April 11, 2010 - 11:32am
tags:
Mylan, NuLytely, laxatives
Positive Results from Optimer Pharmaceuticals' Second Phase 3 Study of Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) Presented at ECCMID
Yahoo/PR NewsWire
Sunday, April 11, 2010 - 11:30am
tags:
Optimer, fidaxomicin, Clostridium Difficile
Most Active Biotech Stocks (SNSS, CTIC, ANX, AMGN, CELG)
EarthTimes
Saturday, April 10, 2010 - 1:17pm
tags:
biotech, investors
Cannasat Therapeutics Announces Private Placement
PR-USA
Saturday, April 10, 2010 - 1:14pm
tags:
Cannasat Therapeutics, Parkinson's Disease, neuropathic pain
Indian Pharmaceutical 4Q FY2010 outlook
Stock Markets Review
Saturday, April 10, 2010 - 1:00pm
tags:
India
Cool Tools for Biotech
Barron's
Saturday, April 10, 2010 - 12:57pm
tags:
Bruker, biotech
Sun Pharma announces USFDA tentative approval for generic Namenda(R) tablets
MarketWatch
Saturday, April 10, 2010 - 12:56pm
tags:
Sun Pharma, Namenda, Alzheimer's disease
Aeterna Zentaris Announces Initiation Of Phase 3 Registration Trial With Perifosine In Refractory Advanced Colorectal Cancer
Medical News Today
Saturday, April 10, 2010 - 12:53pm
tags:
Aeterna Zentaris, colorectal cancer, perifosine
Radient Pharmaceuticals Extends Onko-Sure Cancer Test Distribution Partnership for the Market of India
PR-USA
Saturday, April 10, 2010 - 12:51pm
tags:
Radient Pharmaceuticals, oncology
One-off treatment 'could switch off rheumatoid arthritis'
Telegraph, UK
Saturday, April 10, 2010 - 12:49pm
tags:
rheumatoid arthritis, GSK, otelixizumab
Aurobindo drug receives final approval
Sify
Saturday, April 10, 2010 - 12:46pm
tags:
Aurobindo, Venlafaxine Hydrochloride, Effexor, Wyeth
Seattle Genetics, Takeda & Millennium begin phase-III Aethera trial of brentuximab vedotin for post-transplant Hodgkin lymphoma
Pharmabiz
Saturday, April 10, 2010 - 12:45pm
tags:
Seattle Genetics, Takeda, brentuximab vedotin, Hodgkin's lymphoma
Bristol-Myers Has New CFO, Strong Pipeline
Investors Business Daily
Saturday, April 10, 2010 - 12:35pm
tags:
Bristol-Myers Squibb, Dapagliflozin, coagulants
FDA Panel Deals Blow to Forest
Yahoo/Zacks
Saturday, April 10, 2010 - 12:20pm
tags:
Forest Labs, Daxas, COPD
Finkelstein Thompson LLP Announces Investigation of Medivation, Inc.
Yahoo/Business Wire
Saturday, April 10, 2010 - 12:18pm
tags:
Medivation, dimebon, Alzheimer's disease, investors
Double Your Biotech Returns! Really!
Motley Fool
Saturday, April 10, 2010 - 12:16pm
tags:
investors, biotech, ETFs
Inovio, Drexel, Penn and Cheyney get grant to develop hepatitis C vaccine Read more: Inovio, Drexel, Penn and Cheyney get grant to develop hepatitis C vaccine - Philadelphia Business Journal:
bizjournals.com
Saturday, April 10, 2010 - 12:15pm
tags:
Inovio, hepatitis C
Company Interview: Ligand Pharmaceuticals Inc. - John L. Higgins, President And CEO
Yahoo/Wall St. Transcript
Saturday, April 10, 2010 - 12:13pm
tags:
Ligand
Celgene (analysis)
Investor's Business Daily
Saturday, April 10, 2010 - 12:12pm
tags:
Celgene, anemia, cancer, Chron's Disease
Abbott a Step Closer to FACT
Yahoo/Zacks
Saturday, April 10, 2010 - 12:10pm
tags:
Abbott Laboratories, Facet Biotech, daclizumab, multiple sclerosis, Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.